Gemfibrozil
"Gemfibrozil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established.
Descriptor ID |
D015248
|
MeSH Number(s) |
D02.241.081.114.968.500.750 D02.241.081.944.509.350 D02.355.726.305.750 D02.455.426.559.389.657.654.305.750 D10.251.400.895.593.350
|
Concept/Terms |
Bolutol- Bolutol
- Farmasierra Brand of Gemfibrozil
Trialmin- Trialmin
- Menarini Brand of Gemfibrozil
Decrelip- Decrelip
- Ferrer Brand of Gemfibrozil
Gemhexal- Gemhexal
- Hexal Brand of Gemfibrozil
Gen-Gemfibrozil- Gen-Gemfibrozil
- Gen Gemfibrozil
- GenGemfibrozil
- Genpharm Brand of Gemfibrozil
Jezil- Jezil
- Alphapharm Brand of Gemfibrozil
Lipazil- Lipazil
- Douglas Brand of Gemfibrozil
Litarek- Litarek
- Ipsen Brand of Gemfibrozil
Lopid- Lopid
- Lopid R
- Warner-Lambert Brand of Gemfibrozil
- Warner Lambert Brand of Gemfibrozil
- Pfizer Brand of Gemfibrozil
- United Drug Brand of Gemfibrozil
- Lipur
- Parke Davis Brand of Gemfibrozil
Nu-Gemfibrozil- Nu-Gemfibrozil
- Nu Gemfibrozil
- NuGemfibrozil
- Nu-Pharm Brand of Gemfibrozil
- Nu Pharm Brand of Gemfibrozil
Pilder- Pilder
- Quimifar Brand of Gemfibrozil
PMS-Gemfibrozil- PMS-Gemfibrozil
- PMS Gemfibrozil
- Pharmascience Brand of Gemfibrozil
Apo-Gemfibrozil- Apo-Gemfibrozil
- Apo Gemfibrozil
- ApoGemfibrozil
- Apotex Brand of Gemfibrozil
Ausgem- Ausgem
- Sigma Brand of Gemfibrozil
|
Below are MeSH descriptors whose meaning is more general than "Gemfibrozil".
Below are MeSH descriptors whose meaning is more specific than "Gemfibrozil".
This graph shows the total number of publications written about "Gemfibrozil" by people in UAMS Profiles by year, and whether "Gemfibrozil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 2 | 0 | 2 |
2008 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2002 | 2 | 0 | 2 |
1999 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gemfibrozil" by people in Profiles over the past ten years.
-
Takagi M, Sakamoto M, Itoh T, Fujiwara R. Underlying mechanism of drug-drug interaction between pioglitazone and gemfibrozil: Gemfibrozil acyl-glucuronide is a mechanism-based inhibitor of CYP2C8. Drug Metab Pharmacokinet. 2015 Aug; 30(4):288-94.